Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

9 API Suppliers, 6 USDMF, 3 Listed Suppliers, $ API Reference Price

9 API Suppliers
6 USDMF
3 Listed Suppliers
$ API Reference Price

MARKET PLACE

2 EXCIPIENTS

marketPlace
2 EXCIPIENTS

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 1

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as:

Molecular Formula

C₃₉H₆₆O₂₃

Molecular Weight

902.9 g/mol

InChI Key

VYMFEDXTTBBWFU-ZHACJKMWSA-N

1 2D Structure

SODIUM STARCH GLYOLATE

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

(E)-2-[2-[2-[2-[[3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxymethyl]-6-[4,5-dihydroxy-2-(hydroxymethyl)-6-methyloxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-4-hydroxy-6-(hydroxymethyl)-5-methoxyoxan-3-yl]oxy-2-oxoethyl]dec-3-enoic acid

2.1.2 InChI

InChI=1S/C39H66O23/c1-5-6-7-8-9-10-11-18(36(51)52)12-23(43)60-35-30(50)32(54-4)20(14-41)58-39(35)62-34-22(16-55-37-28(48)26(46)31(53-3)19(13-40)57-37)59-38(29(49)27(34)47)61-33-21(15-42)56-17(2)24(44)25(33)45/h10-11,17-22,24-35,37-42,44-50H,5-9,12-16H2,1-4H3,(H,51,52)/b11-10+

2.1.3 InChI Key

VYMFEDXTTBBWFU-ZHACJKMWSA-N

2.1.4 Canonical SMILES

CCCCCCC=CC(CC(=O)OC1C(C(C(OC1OC2C(OC(C(C2O)O)OC3C(OC(C(C3O)O)C)CO)COC4C(C(C(C(O4)CO)OC)O)O)CO)OC)O)C(=O)O

2.1.5 Isomeric SMILES

CCCCCC/C=C/C(CC(=O)OC1C(C(C(OC1OC2C(OC(C(C2O)O)OC3C(OC(C(C3O)O)C)CO)COC4C(C(C(C(O4)CO)OC)O)O)CO)OC)O)C(=O)O

2.2 Create Date

2008-07-11

3 Chemical and Physical Properties

Molecular Formula	C₃₉H₆₆O₂₃
Molecular Weight	902.9 g/mol
XLogP3	-3.9
Hydrogen Bond Donor Count	11
Hydrogen Bond Acceptor Count	23
Rotatable Bond Count	23
Exact Mass	902.39948835 g/mol
Monoisotopic Mass	902.39948835 g/mol
Topological Polar Surface Area	349 Å²
Heavy Atom Count	62
Formal Charge	0
Complexity	1380
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	21
Defined Bond Stereocenter Count	1
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1